Advanced Chemistry Development, Inc., (ACD/Labs) has announced that it has integrated both of its commercial and freeware ChemSketch application to the Chmoogle Web site, created by eMolecules, Inc.
What will you learn on this course? In this two day advanced course you will learn the advanced tools within the ACD/Labs software. You will be reviewing the ACD/Labs MS Workbook Suite with advanced ...
Within eight years, ACD/Labs has managed to reach a major milestone: the 17th of May, 2006, marks the one millionth download of ACD/Labs freeware software components and products. Coupled with this ...
Open enterprise R&D platform speeds deployment of cutting-edge technology and science SAN DIEGO, Jul 27, 2011 (BUSINESS WIRE) -- Accelrys, Inc. /quotes/zigman/93157 ACCL +5.67% , a leading scientific ...
The informatics company that supports chemical and pharmaceutical R&D sectors said it enhances collaboration between process chemistry, analytical, regulatory and quality departments. Luminata offers ...
TORONTO--(BUSINESS WIRE)--ACD/Labs, an informatics company that develops and commercializes solutions in support of chemical and pharmaceutical R&D, today announced that Boehringer Ingelheim, a ...
ACD/Spectrus Platform enables organizations to apply chemical context to their spectroscopy, spectrometry, and chromatography content. It allows raw or processed data from different instruments, ...
(RTTNews) - Revvity, Inc. (RVTY), a diagnostic and health sciences company, Monday announced that it has entered into a definitive agreement to acquire ACD/Labs, a provider of scientific software ...
WALTHAM, Mass., November 10, 2025--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today announced it has entered into a definitive agreement to acquire ACD/Labs, a global provider of scientific software ...
Acquisition deepens Revvity Signals’ presence in research informatics while furthering its ongoing expansion into development and manufacturing solutions Revvity, Inc. (NYSE: RVTY), today announced it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results